Periscope Capital’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-787,800
Closed -$8.02M 240
2019
Q3
$8.02M Buy
787,800
+129,000
+20% +$1.32M 1.04% 29
2019
Q2
$6.67M Buy
658,800
+49,700
+8% +$500K 0.96% 34
2019
Q1
$6.08M Buy
609,100
+45,200
+8% +$449K 1.05% 35
2018
Q4
$5.53M Buy
563,900
+50,300
+10% +$493K 1.03% 35
2018
Q3
$5M Buy
513,600
+101,600
+25% +$986K 0.95% 43
2018
Q2
$3.96M Buy
+412,000
New +$4M 0.84% 48

Other funds holding AHCO

Periscope Capital's AHCO Position: Q4 2019 in Review

Periscope Capital sold out of AdaptHealth (AHCO) in Q4 2019, closing a stake of 787,800 shares — an estimated $8.02M sold.

Periscope Capital first reported a position in AHCO in Q2 2018 and held it in 6 quarters. The position peaked at $8.02M in Q3 2019. 23 funds tracked by Wall St. Rank hold AHCO as of Q4 2019.

  • Periscope Capital reported no remaining AdaptHealth position as of Q4 2019 after selling out during the quarter.
  • Periscope Capital sold 787,800 AdaptHealth shares in Q4 2019, an estimated $8.02M.
  • Periscope Capital first reported a position in AdaptHealth in Q2 2018 and held it in 6 quarters.
  • Periscope Capital's AdaptHealth position peaked at $8.02M in Q3 2019.
  • 23 funds tracked by Wall St. Rank held AdaptHealth as of Q4 2019.

Based on Periscope Capital's 13F filing for Q4 2019, filed 5 Feb 2020.